Mali: are the drugs as effective as elsewhere?
Medicines are useful for maintaining our health, but the effectiveness of some of them raises questions in Mali. If there is a monitoring mechanism for the licit circuit, many drugs escape this mechanism. In addition, with the storage conditions, it is difficult to guarantee 100% effective drugs from the manufacturer to the consumer.
To guarantee the quality and safety of medicines, there is a device, a mechanism, the Master Plan for the Supply and Distribution of Essential Medicines and other Health Products (SDADME-PS), focusing on medicines in the legal circuit for which administrative and analytical checks are carried out.
The first level of control is the status of the drug in the country of manufacture, which makes it possible to know whether it is authorized there or not, before assessing the other criteria after an analytical control at the National Health Laboratory (LNS). Emphasis is then placed on post-marketing control.
The same drug can be manufactured by several laboratories and have different names without this affecting its effectiveness, whether it is sold here, in Europe or in Asia. This is for example the case of paracetamol-based drugs manufactured by different laboratories, called differently and dosed at 500 mg or 1 g and presented in tablet, syrup or injectable form (galenic form). The differences may therefore also concern the combination of the product with other molecules. Read More…